Three patients with lymphoma were also enrolled, including one with T-lymphoblastic lymphoma in PR, one with refractory Sezary syndrome and 1 with ALK+ anaplastic large cell lymphoma (ALCL) in CR3. This evidence concerns the gene ALK and T-lymphoblastic lymphoma.